2-Naphthyl sulfate, potassium salt, 99 | 21409-32-5

• 物质功能分类: 化学试剂 - 有机试剂 - 磺酸盐/亚磺酸盐
• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2-Naphthyl sulfate, potassium salt, 99
• CAS: 21409-32-5
• 化学式: C10H8KO3S
• 分子量: 247.33
• InChiKey: JBKMJOHAJIZUHK-UHFFFAOYSA-N

物化性质

• 熔点：
  >300°C
• 稳定性/保质期：
  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  1.71
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  62.8
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  29209085
• 储存条件：
  存放于阴凉干燥处。

文献信息

• AMLODIPINE FORMULATIONS
  申请人：Silvergate Pharmaceuticals, Inc.

  公开号：US20190314279A1

  公开（公告）日：2019-10-17

  Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).

  在此提供了稳定的氨氯地平液体制剂。同时还提供了使用氨氯地平液体制剂治疗某些疾病（包括高血压和冠状动脉疾病）的方法。
• Systems and Methods for Treating Ear Disorders and Formulations Therefor
  申请人：YAACOBI Yoseph

  公开号：US20160022666A1

  公开（公告）日：2016-01-28

  An apparatus for insertion in an ear is provided and includes a drug delivery device for insertion into an external auditory canal, wherein the drug delivery device contains one or more pharmaceutically active agents that can be released from the drug delivery device into the external auditory canal and onto the tympanic membrane to treat ear disorders. In more particular instances, the drug delivery device can conform to the profile of the external auditory canal. Formulations of agents for the drug delivery device are also provided.

  提供一种用于插入耳朵的装置，其中包括一个药物输送装置，可插入外耳道，该药物输送装置含有一种或多种药用活性剂，可从药物输送装置中释放到外耳道和鼓膜上，以治疗耳部疾病。在更具体的情况下，药物输送装置可以符合外耳道的轮廓。还提供了药物输送装置的药剂配方。
• Liposome comprising a novel phosphate as membrane constituent, liposome preparations and cosmetic preparations comprising said phosphate
  申请人：KAO CORPORATION

  公开号：EP0370491A2

  公开（公告）日：1990-05-30

  A novel monophosphate and a novel diphosphate prepared by a phosphatidyl transfer reaction of a phospholipid and an alcohol in the presence of phospholipase D are disclosed. The phosphates can independently or together form small and stable liposomes which can include active components therein. Cosmetic compositions comprising these phosphates or liposomes penetrate well into the hair and the skin, and exhibit long-lasting excellent moisture-retaining, beauty, skin-activation effects.

  本研究公开了一种新型单磷酸盐和一种新型二磷酸盐，它们是在磷脂酶 D 的存在下，通过磷脂和醇的磷脂酰转移反应制备的。这些磷酸盐可单独或共同形成小而稳定的脂质体，其中可包含活性成分。包含这些磷酸盐或脂质体的化妆品组合物可以很好地渗透到头发和皮肤中，并表现出持久的出色保湿、美容和活肤效果。
• Amlodipine formulations
  申请人：Silvergate Pharmaceuticals, Inc.

  公开号：US10695329B2

  公开（公告）日：2020-06-30

  Provided herein are stable amlodipine oral liquid formulations. Also provided herein are methods of using amlodipine oral liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).

  本文提供了稳定的氨氯地平口服液制剂。本文还提供了使用氨氯地平口服液制剂治疗某些疾病（包括高血压和冠心病）的方法。
• Liposomes containing biologically active compounds
  申请人：Piedmont Pharmaceuticals, LLC

  公开号：US20030235610A1

  公开（公告）日：2003-12-25

  The present invention provides compositions of liposomes that contain a biologically active compound and methods of manufacture thereof. Invention methods offer the ability to manufacture liposome compositions containing NSAIDs and other biologically active compounds, and the ability to attain very high encapsulation efficiencies in uniform, stable liposomes. Compositions of liposomes containing anti-viral agents and anti-fungal agents are also provided. Invention liposome compositions are useful for the treatment of a variety of conditions, including, for example, pain and inflammation, bacterial infections and viral infections.

  本发明提供了含有生物活性化合物的脂质体组合物及其制造方法。本发明方法提供了制造含有非甾体抗炎药和其他生物活性化合物的脂质体组合物的能力，以及在均匀、稳定的脂质体中实现极高封装效率的能力。本发明还提供了含有抗病毒剂和抗真菌剂的脂质体组合物。本发明的脂质体组合物可用于治疗多种疾病，包括疼痛和炎症、细菌感染和病毒感染等。